SynthesisThe Indian journal of medical research2025
Lipid variations in different polycystic ovary syndrome phenotypes: A systematic review & meta-analysis.
Synthesis in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Polycystic Ovary Syndrome (PCOS) is an endocrine disorder affecting reproductive-age women worldwide. Lipid abnormalities, such as elevated low-density lipoprotein (LDL) and triglyceride (TG) levels and reduced high-density lipoprotein (HDL) levels, are commonly observed in women with PCOS, increasing their risk of cardiovascular disease (CVD). Therefore, this study aims to quantify the magnitude and pattern of lipid levels (total cholesterol, HDL, LDL, and TG) in women with different phenotypes of PCOS versus control women. Methods Worldwide published observational (cross-sectional, case-control, and cohort) studies between January 2010 and December 2024 were systematically searched and assessed using electronic databases, such as PubMed, Google Scholar, Science Direct, and Web of Science-Science Citation Index, where women suffering from different PCOS phenotypes were compared with non-PCOS controls. The association between lipid levels and PCOS was estimated by the mean difference (MD) with a 95% confidence interval (CI). Results The studies included 3655 PCOS patients (phenotype A 1907, phenotype B 474, phenotype C 764, phenotype D 510) and 1824 control participants. Women with the complete phenotype polycystic ovarian morphology plus hyperandrogenism plus ovulatory dysfunction (PCO+HA+O) had increased levels of total cholesterol, LDL cholesterol, and TGs compared to women with other PCOS phenotypes. Total cholesterol was 12.69 mg/dl [95% confidence interval (CI): 8.25, 17.13] in phenotype A. TG levels exhibited the greatest MD in phenotype A and the smallest in phenotype C when compared to control subjects. Interpretation & conclusions The study found significant differences in lipid levels among different PCOS phenotypes compared to control women, highlighting the significance of recognising these differences for cardiovascular risk management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.